IMMUCELL CORPORATION - COMMON STOCK

ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2023

11 5月 2023 16:05:01 条件 Nasdaq GlobeNewswire

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2023

04 5月 2023 06:30:23 条件 Nasdaq GlobeNewswire

ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2023

05 4月 2023 16:05:35 条件 Nasdaq GlobeNewswire

ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2022

21 2月 2023 16:05:00 条件 Nasdaq GlobeNewswire

ImmuCell to Announce Unaudited Financial Results for the Year Ended December 31, 2022

15 2月 2023 11:55:13 条件 Nasdaq GlobeNewswire

ImmuCell Announces Preliminary, Unaudited Sales Results for the Year Ended December 31, 2022

09 1月 2023 16:05:06 条件 Nasdaq GlobeNewswire

ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2022

21 11月 2022 16:05:01 条件 Nasdaq GlobeNewswire

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2022

10 11月 2022 16:05:02 条件 Nasdaq GlobeNewswire

ImmuCell Announces Preliminary, Unaudited Sales Results for Third Quarter of 2022

05 10月 2022 06:30:00 条件 Nasdaq GlobeNewswire

ImmuCell to Participate in the Lytham Partners Fall 2022 Investor Conference

14 9月 2022 17:01:34 条件 Nasdaq GlobeNewswire

ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2022

11 8月 2022 16:05:01 条件 Nasdaq GlobeNewswire

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2022

04 8月 2022 06:30:00 条件 Nasdaq GlobeNewswire

ImmuCell Receives Technical Section Incomplete Letter from FDA Pertaining to Re-Tain®

27 7月 2022 20:05:00 条件 Nasdaq GlobeNewswire

ImmuCell Announces Preliminary, Unaudited Sales Results for Second Quarter of 2022

07 7月 2022 06:30:00 条件 Nasdaq GlobeNewswire

ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders

19 5月 2022 08:00:00 条件 Nasdaq GlobeNewswire

ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2022

12 5月 2022 16:05:02 条件 Nasdaq GlobeNewswire

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2022

10 5月 2022 10:00:00 条件 Nasdaq GlobeNewswire

UPDATE -- Dr. Mark Wustenberg joins ImmuCell as Commercial Leader of Stakeholder Engagement

05 5月 2022 13:17:59 条件 Nasdaq GlobeNewswire

Dr. Mark Wustenberg joins ImmuCell as Commercial Leader of Stakeholder Engagement

05 5月 2022 11:17:08 条件 Nasdaq GlobeNewswire

ImmuCell Announces Record Preliminary, Unaudited Sales Results for First Quarter of 2022

11 4月 2022 16:05:00 条件 Nasdaq GlobeNewswire